- Home
- KNSA vs PCH Comparison
KNSA vs PCH Comparison
Compare KNSA & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- PCH
- Stock Information
- Founded
- KNSA 2015
- PCH 1903
- Country
- KNSA United Kingdom
- PCH United States
- Employees
- KNSA N/A
- PCH N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- PCH Real Estate Investment Trusts
- Sector
- KNSA Health Care
- PCH Real Estate
- Exchange
- KNSA Nasdaq
- PCH Nasdaq
- Market Cap
- KNSA 2.6B
- PCH 3.1B
- IPO Year
- KNSA 2018
- PCH N/A
- Fundamental
- Price
- KNSA $41.77
- PCH $39.67
- Analyst Decision
- KNSA Strong Buy
- PCH Buy
- Analyst Count
- KNSA 6
- PCH 7
- Target Price
- KNSA $51.33
- PCH $46.43
- AVG Volume (30 Days)
- KNSA 461.3K
- PCH 712.6K
- Earning Date
- KNSA 10-28-2025
- PCH 11-03-2025
- Dividend Yield
- KNSA N/A
- PCH 4.52%
- EPS Growth
- KNSA N/A
- PCH 312.61
- EPS
- KNSA 0.47
- PCH 0.82
- Revenue
- KNSA $597,973,000.00
- PCH $1,115,571,000.00
- Revenue This Year
- KNSA $62.63
- PCH $3.29
- Revenue Next Year
- KNSA $29.93
- PCH $3.56
- P/E Ratio
- KNSA $89.00
- PCH $48.57
- Revenue Growth
- KNSA 55.68
- PCH 5.40
- 52 Week Low
- KNSA $17.82
- PCH $36.82
- 52 Week High
- KNSA $42.93
- PCH $48.12
- Technical
- Relative Strength Index (RSI)
- KNSA 64.60
- PCH 46.73
- Support Level
- KNSA $39.61
- PCH $37.69
- Resistance Level
- KNSA $42.93
- PCH $41.52
- Average True Range (ATR)
- KNSA 1.43
- PCH 1.09
- MACD
- KNSA 0.19
- PCH -0.07
- Stochastic Oscillator
- KNSA 79.30
- PCH 51.83
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About PCH PotlatchDeltic Corporation
PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.